Cardinal Health 414 Drug Patent Portfolio
Cardinal Health 414 owns 1 orange book drug protected by 2 US patents Given below is the list of Cardinal Health 414's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9439985 | Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran | 30 Jan, 2029 | Active |
| US6409990 | Macromolecular carrier for drug and diagnostic agent delivery | 12 May, 2025 | Active |
Latest Legal Activities on Cardinal Health 414's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cardinal Health 414.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Mar, 2020 | US9439985 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Jun, 2017 | US9439985 |
|
Email Notification
Critical
| 05 Jun, 2017 | US9439985 |
|
Correspondence Address Change
Critical
| 02 Jun, 2017 | US9439985 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 27 Mar, 2017 | US9439985 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 13 Sep, 2016 | US9439985 |
|
Recordation of Patent Grant Mailed
Critical
| 13 Sep, 2016 | US9439985 |
|
Email Notification
Critical
| 25 Aug, 2016 | US9439985 |
|
Issue Notification Mailed
Critical
| 24 Aug, 2016 | US9439985 |
| Dispatch to FDC | 08 Aug, 2016 | US9439985 |
|
Application Is Considered Ready for Issue
Critical
| 08 Aug, 2016 | US9439985 |
|
Issue Fee Payment Verified
Critical
| 05 Aug, 2016 | US9439985 |
|
Issue Fee Payment Received
Critical
| 05 Aug, 2016 | US9439985 |
| Mail Miscellaneous Communication to Applicant | 31 May, 2016 | US9439985 |
|
Email Notification
Critical
| 31 May, 2016 | US9439985 |
Cardinal Health 414's Family Patents
Cardinal Health 414 drugs have patent protection in a total of 8 countries. It's US patent count contributes only to 27.8% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Cardinal Health 414 Drug List
Given below is the complete list of Cardinal Health 414's drugs and the patents protecting them.
1. Lymphoseek Kit
Lymphoseek Kit is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9439985 | Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran |
30 Jan, 2029
(4 years from now)
| Active |
| US6409990 | Macromolecular carrier for drug and diagnostic agent delivery |
12 May, 2025
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lymphoseek Kit's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List